| Price Range 12mo avg: | $940K – $6.3M |
|---|---|
| $/sf 12mo avg: | $376 |
| CAP Rate 12mo avg: | 6.87% |
| NOI average: | $193,167 |
| Lease Terms: | 15yrs NN |
| Building Size avg: | 8,000 SF |
| Lot Size avg: | 0.75+/- acres |
DaVita Kidney Care is a division of DaVita HealthCare Partners Inc., a Fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of dialysis services in the United States, DaVita Kidney Care treats patients with chronic kidney failure and end stage renal disease. DaVita Kidney Care strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health management services. As of September 30, 2015, DaVita Kidney Care operated or provided administrative services at 2,225 outpatient dialysis centers located in the United States serving approximately 177,000 patients. The company also operated 104 outpatient dialysis centers located in 10 countries outside the United States. DaVita Kidney Care supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu.
DaVita—which is Italian for “giving life”—has more than 50,000 teammates (employees) around the nation working to provide superior patient care and exemplify the company’s Core Values
| S&P Credit Rating: | BB- |
|---|---|
| Moody’s Credit Rating: | Ba3 |
| Annual Revenue 2014: | $12.8B |
| Annual Revenue 2013: | $11.8B |
| Revenue Growth: | ↑ 8.13% from 2013 |
| Net Income | $723M |
| Units (Dec. 2014) | 2,179 |
| Average Units Volume: | $331856K |
Yahoo! Finance: DVA News Latest Financial News for DVA
-
US Markets Green on Thursday
on September 19, 2019 at 8:58 pm
Darden Restaurants falls on financial results Continue reading... […]
-
Jim Chanos unveils short position in kidney-dialysis firm DaVita
on September 19, 2019 at 4:33 pm
Legendary short-seller Jim Chanos of Kynikos Associates on Thursday announced his fund has taken a short position in kidney-dialysis company DaVita Inc. . Chanos, speaking at the CNBC Institutional Investor Delivering Alpha conference, pointed to a recent lawsuit by Blue Cross Blue Shield of Florida Inc. and Health Options Inc. that claims DaVita has engaged in an insurance fraud scheme in an insurance fraud scheme in which it has conspired with the charity the American Kidney Fund to encourage its patients to move from Medicaid and Medicare to private insurance exchanges, with subsidies from the American Kidney Fund, so that it is able to reap higher payments for its services. Chanos said that a whilstleblower from the American Kidney Fund has come forward to claim that DaVita, a major donor to the charity, had directed it to provide funds to its customers. The announcement comes after Chanos had previously criticized the kidney dialysis industry more broadly. DaVita shares fell 2.3% during Thursday trade, and neither the company nor the American Kidney Fund immediately responded a request for comment. […]
-
11 Most Aggressively Shorted Stocks
on September 19, 2019 at 3:15 pm
Traders also look at the activity of short sellers for trading opportunities. Sometimes, stocks with a large amount of short selling activity could be potential candidates for short squeezes. Other times, ... […]
-
5 Low Price-to-Book Stocks to Increase Your Portfolio's Value
on September 18, 2019 at 1:20 pm
P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects. […]
-
Jim Cramer Gives His Opinion On Ulta Beauty, Davita And More
on September 17, 2019 at 3:21 pm
On CNBC's "Mad Money Lightning Round," Jim Cramer said he has not given up on Ulta Beauty Inc (NASDAQ: ULTA ). He thinks it's trading within 10% of a bottom. He wanted to wait until the next ... […]
NYSE: DVA
